CLINICAL TRIAL: NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 ACTG 219这项研究的目的是收集和研究有关您和您的医疗保健的临床和实验室信息，以增加我们对感染艾滋病毒的孕妇及其子女的最佳保健知识。这项研究将考察不同药物在降低感染艾滋病毒母亲所生婴儿感染艾滋病毒方面的效果。研究还将研究不同药物如何降低血液中的病毒数量或增加帮助身体对抗感染的血细胞。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219 The purpose of this study is to collect and study clinical and laboratory information about you and your medical care in order to increase our knowledge of the best care for HIV-infected pregnant women and their children. The study will look at how good different medications are in lowering the chance that a baby born to an HIV-infected mother will get HIV.The study will also look at how different medicines work to lower the amount of virus in the blood or increase the blood cells that help the body fight infection.